Netherlands anti-aging therapeutics market is projected to grow from $2 Mn in 2022 to $6 Mn in 2030 with a CAGR of 17.03% for the year 2022-2030. Technological advancements in the form of new and inventive therapeutics in the Netherlands as well as increased R&D efforts in the Netherlands are responsible for the market expansion. The Netherlands anti-aging therapeutics market is segmented by product, treatment, target group, type of aging, type of molecules, mechanism of action, ingredient, and by distribution channel. KEI Biotechnology, AHV International, and Biosplice are the major players in the market.
The Netherlands anti-aging therapeutics market size is at around $2 Mn in 2022 and is projected to reach $6 Mn in 2030, exhibiting a CAGR of 17.03% during the forecast period. With a total score of 59.86, the Dutch healthcare system comes in third place in the 2022 World Index of Healthcare Innovation, behind only Switzerland and Ireland. In 2021, the Netherlands placed second, and in 2020, third. The Netherlands performed well overall, finishing no lower than 10th in any category (for Quality). In order to be more prepared for potential pandemics, the Dutch government will place a greater emphasis on international collaboration and strengthening health systems all over the world. Furthermore, the effects of climate change on public health will receive additional attention. Additionally, the Netherlands will increase its spending on foreign health from $116 Mn in 2023 to $143 Mn in 2026.
In the Netherlands, the elderly population has been steadily growing, which has increased the demand for anti-aging health goods to ensure longevity and to lessen age-related complications. Nicotinamide mononucleotide (NMN), one of many anti-aging health products, has caught the interest of both consumers and researchers. Age-related declines in nicotinamide adenine dinucleotide (NAD+) levels are linked to cognitive decline, oxidative stress, DNA damage, and inflammatory diseases. NAD+ is also connected with the downregulation of mitochondrial energy production. However, by raising the body's amount of NAD+, NMN, the precursor to NAD+, can slow this process down. Numerous in vivo studies have shown that NMN supplementation has positive therapeutic benefits for a variety of age-induced complications.
Numerous in vivo studies have revealed that NMN has a broad range of pharmacological activities in addition to its anti-aging potential. There has been significant research on the relationship between NMN and the prevalence of Alzheimer's disease, obesity and its complications, cerebral and cardiac ischemia, and age- and diet-induced type 2 diabetes. Although the scientific community in the Netherlands previously focused on NMN only as an intermediate in the biosynthesis of NAD+, lately a number of pharmacological activities triggered by rising levels of NAD+ in the body, particularly anti-aging activity, have come to the fore.
Market Growth Drivers Analysis
The Netherlands is one of many developed nations with an aging population due to a sharp rise in the proportion of individuals 65 and older. The Netherlands anti-aging therapeutics market is expanding as a result of the changing demographics, which has raised the demand for anti-aging products and therapies. New and inventive anti-aging therapies and goods have been designed as a result of technological advancements. Consumers find these new goods more appealing because they are more efficient and come with fewer side effects than conventional treatments. The Dutch government is actively encouraging the growth of the healthcare sector, including the market for anti-aging therapeutics. This assistance comes in the form of grants for R&D and tax breaks for businesses operating in the sector. The Netherlands anti-aging therapeutics market is anticipated to expand as a result of this support.
Market Restraints
In the Netherlands, the regulatory environment for anti-aging products and therapies is complex, which may restrict market development. Production and commercialization of new treatments could be delayed down if companies have trouble getting regulatory approvals for new goods and therapies. The acceptance of anti-aging therapies and goods may be constrained by consumer uncertainty about their efficacy. This might restrict the Netherlands anti-aging therapeutics market expansion, especially among consumers. Some anti-aging treatments and products come with serious risks and side effects, which may discourage customers from using them. This might prevent the market from expanding.
Key Players
The Medicines Evaluation Board (MEB) is the Dutch regulatory authority in charge of regulating and approving anti-aging medications. The Dutch Ministry of Health, Welfare, and Sport oversees the MEB as an independent agency. Its primary duty is to assess and authorize new medications and medical equipment for use in the Netherlands. To receive approval for an anti-aging drug, companies must present an archive of information to the MEB that demonstrates the product's safety, efficacy, and quality. Following an evaluation of the dossier, the MEB will decide whether or not to approve the drug for use in the Netherlands. The MEB also keeps an eye on the security of medicines that are already on the market and has the power to take action if it notices any security problems or issues. If a product is discovered to be unsafe, it may be necessary for businesses to alter the labeling on the product or even remove it from the market.
1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment
6. Methodology and Scope
By Product (Revenue, USD Billion):
By Treatment (Revenue, USD Billion):
By Target Group (Revenue, USD Billion):
By Type of Aging (Revenue, USD Billion):
By Type of Molecules (Revenue, USD Billion):
By Mechanism of Action (Revenue, USD Billion):
By Ingredient (Revenue, USD Billion):
By Distribution Channel (Revenue, USD Billion):
Insights10 will provide you with the reports within 10 key parameters which are:
Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.
Stage I: Market Data Collection
Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.
Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.
Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:
Stage II: Market Data Analysis and Statistical Model
Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.
Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.
The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.
The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.
Data Triangulation & Validation:
Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.
We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.
Stage III: Interpretation and Presentation
Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)
Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.
Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.
This report addresses
Need more?